Digestive/GI side effects are common: nausea, vomiting, diarrhea, constipation, delayed gastric emptying (gastroparesis) have all been documented
Semaglutide works on receptors involved in appetite regulation and blood sugar control
Commonly experienced outcomes are dyspepsia showing-up as discharge of loose stools accompanied by vomiting and nausea
When fatty acids struggle to move efficiently into the mitochondria, your body leans more heavily on glycogen
n=306 ALC, n=299 control), the pooled estimate favored ALC (SMD 1.38, 95% CI 2.41 to 0.34
Empagliflozin The pharmacokinetics of empagliflozin has been characterized in healthy volunteers and patients with type 2 diabetes mellitus and no clinically relevant differences were noted between the two populations